Back to Results
First PageMeta Content
Fabry disease / Alpha-galactosidase / Kidney diseases / Enzyme replacement therapy / Fabry / Genzyme / Antibody / Chronic kidney disease / Biomarker / Medicine / Health / Biology


Microsoft PowerPoint - Fabry Registry annual report figures redrawn Alison FINAL 2012 revised 2.ppt [Compatibility Mode]
Add to Reading List

Document Date: 2014-10-06 18:39:38

Open Document

File Size: 1,50 MB

Share Result on Facebook

City

Cambridge / /

Company

IgG / Advisors Fabry Registry Annual Report 2012 Introduction / GE / Genzyme / Sanofi company / /

Continent

North America / Europe / /

/

Event

FDA Phase / /

/

IndustryTerm

treatment for Fabry disease / /

MedicalCondition

proteinuria / inherited metabolic diseases / Chronic / stroke / Fabry disease / albuminuria / lung cancer / overt proteinuria / allergic reactions / cardiac disease / Renal disease / end-stage renal disease / illness / advanced kidney disease / /

MedicalTreatment

enzyme replacement therapy / dialysis / renal transplant / /

Organization

International Board / Board of Advisors Fabry Registry Annual Report / Board of Advisors David W. Warnock / FDA / Christoph Wanner Fabry Registry International Board / Fabry Registry Board / Fabry Registry European Board / /

Person

Phil Lee / Christoph Wanner / David W. Warnock / Philip Lee / Juan Manuel Politei / /

/

Position

Board member / Advisors / Major / consultant / /

Product

Fabrazyme / Fabrazyme® / /

Region

Latin America / Asia Pacific / /

Technology

Antibodies / dialysis / /

SocialTag